Ginsenoside Rg1 improves hypoxia-induced pulmonary vascular endothelial dysfunction through TXNIP/NLRP3 pathway-modulated mitophagy. [PDF]
Zhang R +5 more
europepmc +1 more source
Ginsenoside Rg1 inhibits multiple myeloma and overcomes bortezomib resistance through AMPK-mTOR pathway. [PDF]
Lin L, Chen D, Li S, Wang T.
europepmc +1 more source
Ginsenoside Rg1 exerts anti-arrhythmic effect by inhibiting I<sub>CaL</sub> through cAMP-PKA and PI3K-AKT signaling pathways in rat ventricular myocytes after myocardial ischemia-reperfusion injury. [PDF]
Wang T +7 more
europepmc +1 more source
Ginsenoside Rg1 reduces cardiac inflammation against myocardial ischemia/reperfusion injury by inhibiting macrophage polarization. [PDF]
Xu X +10 more
europepmc +1 more source
Effect of ginsenoside Rg1 on hematopoietic stem cells in treating aplastic anemia in mice via MAPK pathway. [PDF]
Wang JB, Du MW, Zheng Y.
europepmc +1 more source
[Corrigendum] Ginsenoside Rg1 inhibits inflammatory responses via modulation of the nuclear factor‑κB pathway and inhibition of inflammasome activation in alcoholic hepatitis. [PDF]
Li J +7 more
europepmc +1 more source
Ginsenoside Rg1 mitigates cerebral ischaemia/reperfusion injury in mice by inhibiting autophagy through activation of mTOR signalling. [PDF]
Xi ZC +10 more
europepmc +1 more source
Author Correction: Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway. [PDF]
Chu SF +12 more
europepmc +1 more source
Retracted: Effects of Ginsenoside Rg1 on the Biological Activity of Human Periodontal Ligament Cells. [PDF]
International BR.
europepmc +1 more source

